NORWOOD, Mass.--(BUSINESS WIRE)--March 10, 2005-- Apogee Technology, Inc. (AMEX:ATA), a global provider of silicon-based innovations for specialized commercial applications, announced it has signed an agreement with the University of Medicine and Dentistry New Jersey’s (UMDNJ) Laboratory for Drug Delivery to conduct research and testing on the company’s proprietary, MEMS-based transdermal drug delivery device.
